Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori bought 220 shares of Dr. Martens stock in a transaction on Monday, October 12th. The shares were bought at an average cost of GBX 68 per share, with a total value of £149.60.
Ije Nwokori also recently made the following trade(s):
- On Friday, October 16th, Ije Nwokori sold 209,160 shares of Dr. Martens stock. The shares were sold at an average price of GBX 69, for a total value of £144,320.40.
- On Friday, September 11th, Ije Nwokori purchased 232 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 65 per share, for a total transaction of £150.80.
- On Tuesday, August 11th, Ije Nwokori acquired 179 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 84 per share, with a total value of £150.36.
Dr. Martens Price Performance
DOCS stock opened at GBX 68.80 on Friday. The firm has a 50 day moving average of GBX 73.05 and a 200-day moving average of GBX 71.03. The company has a current ratio of 2.61, a quick ratio of 1.13 and a debt-to-equity ratio of 108.85. Dr. Martens plc has a 12 month low of GBX 59.15 and a 12 month high of GBX 97.05. The firm has a market capitalization of £658.53 million, a P/E ratio of 28.67, a price-to-earnings-growth ratio of 6.40 and a beta of 0.26.
Analysts Set New Price Targets
Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 110 price target on shares of Dr. Martens in a research report on Friday, October 9th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 105.
Read Our Latest Stock Analysis on DOCS
Dr. Martens Company Profile
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Featured Articles
- Five stocks we like better than Dr. Martens
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
